EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling

Hongji Zhou, Rui Zhang, Min Li, Fuyan Wang, Yuxia Gao, Kehua Fang iD, Jinbao Zong iD, Xiaotian Chang iD

Journal of Immunology Research · 2024

DOI: 10.1155/2024/5009637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology Research, 2024. Verfasst von Hongji Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Center The Affiliated Hospital of Qingdao University, Wutaishan Road 1677, Qingdao 266000, China. Hauptthemen laut MEDLINE: Atherosclerosis, Disease Models, Animal, Inflammation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Technology Research and Development Program of Shandong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It has been reported that carbonic anhydrase I (CA1) is a target for the diagnosis and therapy of atherosclerosis (AS) since CA1 can promote AS aortic calcification. We also found that methazolamide (MTZ), a drug for glaucoma treatment and an inhibitor of carbonic anhydrases, can treat AS by inhibiting calcification in aortic tissues. This study focused on the therapeutic mechanism of MTZ and the pathogenic mechanism of AS. In this study, a routine AS animal model was established in ApoE−/− mice, which were treated with MTZ. The aortic tissues were analyzed using single‐cell sequencing. MTZ significantly increased the proportions of B‐1/MZB B cells with high expressions of Nr4A1 and Ccr7, CD8+CD122+ Treg‐like cells with high Nr4A1 expression, and smooth muscle cells with high Tpm2 expression. These cells or their marker genes were reported to exert immunosuppressive, anti‐proinflammatory, and atheroprotective effects. MTZ also decreased the proportions of endothelial cells with high expressions of Retn, Apoc1, Lcn2, Mt1, Serpina3, Lpl, and Lgals3; nonclassical CD14+CD16++ monocytes with high expressions of Mt1, Tyrobp, Lgals3, and Cxcl2; and Spp1+ macrophages with high expressions of Mmp‐12, Trem2, Mt1, Lgals3, Cxcl2, and Lpl. These cells or their marker genes have been reported to promote inflammation, calcification, tissue remodeling, and atherogenesis. A significant decrease in the proportion of CD8+CD183 (CXCR3)+ T cells, the counterpart of murine CD8+CD122+ T cells, was detected in the peripheral blood of newly diagnosed AS patients rather than in that of patients receiving anti‐AS treatments. These results suggest that MTZ can treat AS by increasing immunosuppressive cells and decreasing expressions of genes related to inflammation, calcification, and tissue remodeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisDisease Models, AnimalInflammationAnimalsMiceHumansAortaMaleGene Expression RegulationApolipoproteins ECalcinosis

Substanzen

Apolipoproteins E

Autor:innen und Institutionen

  • Medical Research Center The Affiliated Hospital of Qingdao University, Wutaishan Road 1677, Qingdao 266000, China.
  • Department of Cardiology The Affiliated Hospital of Qingdao University, Wutaishan Road 1677, Qingdao 266000, China.
  • Clinical Laboratory and Central Laboratory Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Road Renmin 4, Qingdao 266033, Shandong Province, China.
  • Shandong Engineering Research Center of Bacterial Anti-tumor Drugs and Cell Therapy, Jingshi Road 7000, Jinan 250000, Shandong Province, China.
  • Clinical Laboratory The Affiliated Hospital of Qingdao University, Wutaishan Road 1677, Qingdao, Shandong 266000, China.

ORCID-Profile: Kehua Fang, Jinbao Zong, Xiaotian Chang

Förderung

  • Key Technology Research and Development Program of Shandong

Zitieren

APA

Zhou, H., Zhang, R., Li, M., Wang, F., Gao, Y., Fang, K., Zong, J., & Chang, X. (2024). Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling. Journal of Immunology Research. https://doi.org/10.1155/2024/5009637

Vancouver

Zhou H, Zhang R, Li M, Wang F, Gao Y, Fang K, et al. Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling. Journal of Immunology Research. 2024. doi:10.1155/2024/5009637

BibTeX
@article{Zhou2024,
  author = {Zhou, Hongji and Zhang, Rui and Li, Min and Wang, Fuyan and Gao, Yuxia and Fang, Kehua and Zong, Jinbao and Chang, Xiaotian},
  title = {Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling},
  journal = {Journal of Immunology Research},
  year = {2024},
  doi = {10.1155/2024/5009637}
}
Kostenlos starten →